Here we report that myeloid cells differentiating along the monocyte/macrophage lineage down-regulate the ST6Gal-I sialyltransferase via a protein kinase C/Ras/ERK signaling cascade. In consequence, the 1 integrin subunit becomes hyposialylated, which stimulates the ligand binding activity of ␣51 fibronectin receptors. Pharmacologic inhibitors of protein kinase C, Ras, and MEK, but not phosphoinositide 3-kinase, block ST6Gal-I down-regulation, integrin hyposialylation, and fibronectin binding. In contrast, constitutively active MEK stimulates these same events, indicating that ERK is both a necessary and sufficient activator of hyposialylationdependent integrin activation. Consistent with the enhanced activity of hyposialylated cell surface integrins, purified ␣51 receptors bind fibronectin more strongly upon enzymatic desialylation, an effect completely reversed by resialylation of these integrins with recombinant ST6Gal-I. Finally, we have mapped the N-glycosylation sites on the 1 integrin to better understand the potential effects of differential sialylation on integrin structure/function. Notably, there are three N-glycosylated sites within the 1 I-like domain, a region that plays a crucial role in ligand binding. Our collective results suggest that variant sialylation, induced by a specific signaling cascade, mediates the sustained increase in cell adhesiveness associated with monocytic differentiation.The U937 and THP-1 cell lines represent well accepted model systems for studying myeloid differentiation along the monocyte/macrophage lineage. Following treatment with phorbol myristate acetate (PMA), 4 these cells exhibit phenotypic changes that are characteristic of cell differentiation, including increased respiratory burst activity, enhanced phagocytotic capability, and markedly elevated cell adhesiveness to extracellular matrix ligands such as fibronectin. In vivo, the increased adhesiveness of monocytes/macrophages contributes to the extravasation of cells from the vasculature as well as tethering of cells within inflamed tissues.Differentiating myeloid cells bind to fibronectin through the integrin family of cell adhesion receptors, including the ␣51 integrin species. The molecular mechanisms underlying PMA-dependent cell adhesion have not been well defined, although it has been reported that PMA increases the synthesis of both ␣5 and 1 integrin subunits (1-4). However, myeloid cells (U937 and THP-1) express an abundant amount of ␣51 in the absence of PMA treatment, and yet these cells bind very poorly to fibronectin. This suggests that myeloid ␣51 receptors are normally in an inactive state and that increased expression alone cannot account for the dramatically increased fibronectin binding induced by PMA.In our prior study (5) we observed that PMA stimulated a rapid but transient increase in fibronectin binding that was likely due to the activation of integrins already present on the cell surface. However, following this initial transient event there was a second phase of elevated fibronect...